Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 89, Issue 1, 2018, Pages 28-33

  Azary, Saeedeh ^a   Schreiner, Teri ^b   Graves, Jennifer ^a   Waldman, Amy ^c   Belman, Anita ^d   Guttman, Bianca Weinstock ^e   Aaen, Gregory ^f   Tillema, Jan Mendelt ^g   Mar, Soe ^h   Hart, Janace ^a   Ness, Jayne ⁱ   Harris, Yolanda ⁱ   Krupp, Lauren ^j   Gorman, Mark ^k   Benson, Leslie ^k   Rodriguez, Moses ^g   Chitnis, Tanuja ^k   Rose, John ^l   Barcellos, Lisa F ^m   Lotze, Tim ⁿ   Carmichael, Suzan L ^o   Roalstad, Shelly ^l   Casper, Charles T ^l   Waubant, Emmanuelle ^a   more..

^a UCSF Regional Pediatric MS Center   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e JACOBS NEUROLOGICAL INSTITUTE   (United States)

^f LOMA LINDA UNIVERSITY   (United States)

^g MAYO CLINIC   (United States)

^h WASHINGTON UNIVERSITY   (United States)

ⁱ Alabama Pediatric MS Center   (United States)

^j NEW YORK UNIVERSITY   (United States)

^k BOSTON CHILDREN S HOSPITAL   (United States)

^l UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ BAYLOR COLLEGE OF MEDICINE   (United States)

^o STANFORD UNIVERSITY   (United States)

more..

Author keywords

Diet; Fat intake; Multiple sclerosis; Pediatric; relapse; Vegetable intake

Indexed keywords

CALCIFEDIOL; SATURATED FATTY ACID;

ADOLESCENT; ARTICLE; BLOCK KIDS FOOD SCREENER; CALORIC INTAKE; CHILD; CLINICAL OUTCOME; CONTROLLED STUDY; DEMYELINATING DISEASE; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE DURATION; FAT INTAKE; FEMALE; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; SCHOOL CHILD; SCREENING TEST; UNITED STATES; VEGETABLE; VITAMIN BLOOD LEVEL; ADMINISTRATION AND DOSAGE; CLINICAL TRIAL; RISK FACTOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIETARY FATS; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RISK FACTORS; UNITED STATES; VEGETABLES;

EID: 85040003946     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2017-315936     Document Type: Article

References (40)

1. Mandia D, Ferraro OE, Nosari G, et al. Environmental factors and multiple sclerosis severity: a descriptive study. Int J Environ Res Public Health 2014;11:6417-32.
2. Ascherio A. Environmental factors in multiple sclerosis. Expert Rev Neurother 2013;13:3-9.
3. Weston M, Constantinescu CS. What role does tobacco smoking play in multiple sclerosis disability and mortality? A review of the evidence. Neurodegener Dis Manag 2015;5:19-25.
4. Mowry EM, Krupp LB, Milazzo M, et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 2010;67:618-24.
5. Timmermans S, Bogie JF, Vanmierlo T, et al. High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the Renin Angiotensin system. J Neuroimmune Pharmacol 2014;9:209-17.
6. Agranoff BW, Goldberg D. Diet and the geographical distribution of multiple sclerosis. Lancet 1974;2:1061-6.
7. Hadgkiss EJ, Jelinek GA, Weiland TJ, et al. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci 2015;18:125-36.
8. Gorman MP, Healy BC, Polgar-Turcsanyi M, et al. Increased relapse rate in pediatriconset compared with adult-onset multiple sclerosis. Arch Neurol 2009;66:54-9.
9. Casper TC, Rose JW, Roalstad S, et al. The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol 2015;30:1381-7.
10. Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013;19:1261-7.
11. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
12. Nutrition Quest. Assessment Tools. Block '98 FFQ. 2017. http://www.nutritionquest.com/products/questionnaires-screeners.htm (accessed 1 Oct 2007).
13. Hunsberger M, O'Malley J, Block T, et al. Relative validation of Block Kids Food Screener for dietary assessment in children and adolescents. Matern Child Nutr 2015;11:260-70.
14. Mowry EM, Pelletier D, Gao Z, et al. Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection. Eur J Neurol 2016;23:327-32.
15. McDonald J, Graves J, Waldman A, et al. A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Mult Scler Relat Disord 2016;6:87-92.
16. Nourbakhsh B, Graves J, Casper TC, et al. Dietary salt intake and time to relapse in paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry 2016;87:1350-3.
17. Mozaffarian D, Pischon T, Hankinson SE, et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004;79:606-12.
18. Lopez-Garcia E, Schulze MB, Meigs JB, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005;135:562-6.
19. Moschen AR, Wieser V, Tilg H. Dietary Factors: Major Regulators of the Gut's Microbiota. Gut Liver 2012;6:411-6.
20. Alter M, Yamoor M, Harshe M. Multiple sclerosis and nutrition. Arch Neurol 1974;31:267-72.
21. Milanski M, Degasperi G, Coope A, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 2009;29:359-70.
22. Ghadirian P, Jain M, Ducic S, et al. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 1998;27:845-52.
23. Hoare S, Lithander F, van der Mei I, et al. Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study. Mult Scler 2016;22:884-92.
24. Zhang SM, Willett WC, Hernán MA, et al. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 2000;152:1056-64.
25. Weinstock-Guttman B, Baier M, Park Y, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids 2005;73:397-404.
26. Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990;336:37-9.
27. Yadav V, Marracci G, Kim E, et al. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Mult Scler Relat Disord 2016;9:80-90.
28. Zhornitsky S, McKay KA, Metz LM, et al. Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes. Mult Scler Relat Disord 2016;5:53-65.
29. Cermenati G, Brioschi E, Abbiati F, et al. nervous system, and lipid metabolism. J Endocrinol Invest 2013;36:435-43.
30. Weinstock-Guttman B, Zivadinov R, Mahfooz N, et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation 2011;8:127.
31. Tettey P, Simpson S, Taylor B, et al. An adverse lipid profile is associated with disability and progression in disability, in people with MS. Mult Scler 2014;20:1737-44.
32. Giubilei F, Antonini G, Di Legge S, et al. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand 2002;106:109-12.
33. Weinstock-Guttman B, Zivadinov R, Horakova D, et al. Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event. J Neurol Neurosurg Psychiatry 2013;84:1186-91.
34. Tettey P, Simpson S, Taylor B, et al. Adverse lipid profile is not associated with relapse risk in MS: results from an observational cohort study. J Neurol Sci 2014;340:230-2.
35. Schwingshackl L, Hoffmann G. Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials. Nutr Metab Cardiovasc Dis 2014;24:929-39.
36. Gusev E, Boiko A, Lauer K, et al. Environmental risk factors in MS: a case-control study in Moscow. Acta Neurol Scand 1996;94:386-94.
37. Ghanim H, Abuaysheh S, Sia CL, et al. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 2009;32:2281-7.
38. van Rensburg SJ, Kotze MJ, van Toorn R. The conundrum of iron in multiple sclerosis-time for an individualised approach. Metab Brain Dis 2012;27:239-53.
39. Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med 2006;99:589-93.
40. Lynch SG, Fonseca T, LeVine SM. A multiple course trial of desferrioxamine in chronic progressive multiple sclerosis. Cell Mol Biol 2000;46:865-9.